iSpecimen’s technology provides data-rich human biospecimens to medical researchers1-10 Employees
iSpecimen Funding
$0
22 rounds
iSpecimen is active in the following markets / industries: biotechnology, health care, health care information technology and clinical trials. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on September 4, 2014.